Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 797 of 1,261
  1. US 8809516

    Therapeutic compositions

    Alnylam Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  2. US 8809400

    Method to ameliorate oxidative stress and improve working memory via pterostilbene administration

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  3. US 8809372

    Pyridine derivatives

    Asana BioSciences, LLC · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  4. US 8809453

    Branched polymers

    Nektar Therapeutics · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  5. US 8809370

    AMPK-activating heterocyclic compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  6. US 8809347

    Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as AXL inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  7. US 8809268

    Combination therapy to combat helminth resistance

    The Regents of the University of California · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  8. US 8809269

    Therapeutic agent preparations comprising insulin for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  9. US 8809310

    Use of rasagiline for the treatment of multiple system atrophy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  10. US 8809335

    Pyrazolopyrimidine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  11. US 8809364

    Polycyclic aryl substituted triazoles and polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  12. US 8809377

    Deubiquitinase inhibitors and methods for use of the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  13. US 8809292

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Alnylam Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  14. US 8809293

    Compositions and methods for inhibiting gene expression of hepatitis B virus

    Arrowhead Madison, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  15. US 8809271

    Therapeutic agent preparations comprising liraglutide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  16. US 8809291

    Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma

    The Regents of the University of California · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  17. US 8809323

    Therapeutic applications of pro-apoptotic benzodiazepines

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  18. US 8809353

    Quinazolines useful as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  19. US 8809319

    Substituted 8-oxa-10,11-dihydroimidazo[2,3-a]bicyclo[3.2.1]oct-3-enes and use thereof as an insecticide

    East China University of Science and Technology · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  20. US 8809515

    Methods and compositions for the specific inhibition of gene expression by double-stranded RNA

    INTEGRATED DNA TECHNOLOGIES, INC. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  21. US 8809502

    Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  22. US 8808710

    Method of preparing an immunologically-active adjuvant-bound dried vaccine composition

    The Regents of the University of Colorado, a Body Corporate · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  23. US 8808866

    Coated elastomeric article and method for making a coated elastomeric article

    Precision Components, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  24. US 8809264

    Quinoxalinyl macrocyclic hepatitis C virus serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.